


   Vivian Liu | NexMed , Inc. | ZoomInfo.com










 





INNV Vivian H. Liu Insider Trades for Innovus Pharmaceuticals Inc.


































X

Tweet
 

Share this bulletin

Get news bulletins by email

Bulletin

Sean Spicer resigns as Trump's press secretary: New York Times »
        




Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Innovus Pharmaceuticals Inc.

                  OTC: INNV
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Innovus Pharmaceuticals Inc.



Market open
 --Quotes are delayed by 20 min
Jul 21, 2017, 11:07 a.m.


INNV

/quotes/zigman/11137224/delayed


$
0.12




Change

+0.0025
+2.07%

Volume
Volume 21,250
Quotes are delayed by 20 min








/quotes/zigman/11137224/delayed
Previous close

$
			0.12
		


$
				0.12
			
Change

+0.0025
+2.07%





Day low
Day high
$0.12
$0.13










52 week low
52 week high

            $0.08
        

            $0.66
        


















Insider Activity


Individual




Vivian H. Liu



Ms. Vivian H. Liu is an Advisor at Brinson Patrick Securities Corp. She is on the Board of Directors at Innovus Pharmaceuticals, Inc. In 1995, she co-founded NexMed, Inc., which was renamed Apricus Biosciences, Inc. in 2010. Ms. Liu served as NexMed's President and Chief Executive Officer from 2007-2009 after having served in various executive capacities, including Executive Vice President and Chief Operating Officer, interim CEO, as well as Chief Financial Officer and Vice President of Corporate Affairs.
Ms. Liu was appointed to the NEXM Board of Directors in 2007 and served as its Chairman of the Board from 2009 to 2010. Prior to co-founding NexMed, Ms. Liu was the Commercial Attaché with the Delegation of Quebec in Los Angeles, responsible for business development projects for the medical, pharmaceutical and biotechnology industries. Ms. Liu has an M.P.A. from the University of Southern California, and a B.A. from University of California, Berkeley.
Ms. Liu is currently President & CEO of FasTrack Pharmaceuticals, Inc., a privately-held company focusing on the development of innovative pharmaceutical products.



Transactions


Date
Shares
Transaction
Value





01/02/2015
18,750


 
Award at $0 per share.


0


12/18/2014
135,000


 
Gift at $0 per share.


0


10/01/2014
8,108


 
Award at $0 per share.


0


07/01/2014
11,111


 
Award at $0 per share.


0


04/01/2014
7,317


 
Award at $0 per share.


0


02/19/2014
146,014


 
Derivative/Non-derivative trans. at $0 per share.


0


02/04/2014
7,500


 
Award at $0 per share.


0


10/16/2013
3,750


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. Bassam B. Damaj 
President, Chief Executive Officer & Director




Mr. Rauly  Gutierrez 
Chief Financial & Accounting Officer




Ms. Vivian H. Liu 
Director




Mr. Robert C. Verfurth 
Vice President-Sales & Marketing




Mr. Randy J. Berholtz 
Secretary, Executive VP & General Counsel




Dr. Henry Jemil Esber 
Chairman




Dr. Ziad  Mirza 
Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




12:20 PM EDT
July 21, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
12:19pGE’s stock tumbles as outgoing CEO Immelt ends reign with dim outlook
12:18pThese tips can help advisers attract — and keep — high net worth clients
12:06pHow Trump’s ‘greatest tax cut in history’ may impact you, in one simple calculator
12:06pBREAKINGWhite House press secretary Sean Spicer resigns, reports say 
12:04pWeekend roundup: Companies that may cut dividends | FAANG stocks and market bubbles | Enjoy London on the cheap
12:03pWhite House press secretary Sean Spicer resigns: reports
12:02pIf you care about the planet, don’t buy so much
12:00pThe reason Jack Bogle doesn’t fly first class says everything about his investing legacy
11:55aVornado Realty Trust stock price target cut to $81 from $95 at Morgan Stanley
11:54aAir France’s new millennial airline may be less annoying than it sounds
11:53aMicrosoft stock price target raised to $82 from $73 at UBS
11:53aGold aims for a second-straight weekly gain and highest finish in a month 
11:53aVisa stock price target raised to $112 from $102 at UBS
11:52aE-Trade stock price target raised to $48 from $44 at UBS
11:52aEBay stock price target raised to $40 from $38 at UBS
11:51aNIC Inc. downgraded to neutral from buy at Sidoti & Co.
11:41aTreasury yields fall as dovish comments from ECB’s Draghi fuel bond buying
11:35aWhy you might want to avoid these 30 dividend stocks
11:35aAttention, shoppers: ‘Amazon effect’ is creating bargain stocks
11:34aBREAKINGTrump orders report on how U.S. defense and industry are sourced
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,556.91

-54.87
-0.25%





nasdaq

/quotes/zigman/12633936/realtime
6,382.09

-7.92
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,469.82

-3.63
-0.15%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15






























































Vivian H. Liu - Biography

















































































Log in






E-mail



Password







Remember




Forgot password ?









Become a member for free
Sign up





Sign up




New memberSign up for FREE


New customerDiscover our portfolios












 United States
 United Kingdom
 France
 Deutschland
 Schweiz (DE)
 Suisse (FR)










Settings

            Dynamic quotes 


OFFON

















Markets
Equities
North AmericaEuropeAsiaOceaniaMiddle East� More Equities

Indexes
DOW JONESS&P 500NASDAQ 100TSX COMPFTSE 100� More Indexes

Currency / Forex
EUR / USDGBP / USDUSD / JPYUSD / CADAUD / USD� More Currencies

Commodities
GOLDCrude Oil (WTI)Crude Oil (BRENT)SILVERPLATINUM� More Commodities


 News
Latest News
CompaniesMarketsEconomyCurrency / ForexCommoditiesInterest RatesBusiness LeadersFinancial calendarEconomic calendar

Listed company
Analyst reco.RumorsIPOsCapital Markets TransactionsNew ContractsProfits warningsAppointmentsPress ReleasesEventsCorporate actions

Sector News
EnergyBasic MaterialsIndustrialsConsumer CyclicalConsumer Non-CyclicalFinancialsHealthcareTechnologyTelecommunications ServicesUtilities


 Analysis
All AnalysisCommentariesIndex AnalysisStock Trading StrategiesCommodity AnalysisForex Analysis

 Stock Picks
All stock picks

 Portfolios
My Portfolio
Virtual portfolios
4-Traders Portfolios
European PortfolioUSA PortfolioAsian Portfolio


 Screeners
Market Screener HomeFundamental Analyse
Top Investor RatingTop Trading RatingTop ConsensusGrowth stocksYield stocksLow valuations

Technical Analysis
Oversold stocksOverbought stocksClose to resistancesClose to supportsAccumulation phaseMost volatile stocks


 Watchlists
My Watchlists
Watchlists
Top Lists
Yield stocksGrowth stocksUndervalued Stocks


 Top / Flop
Top News
Most Read NewsHot News

Top Fundamentals
Top CapitalizationTop YieldTop PERTop ConsensusTop Fundamentals

Top Technicals
Top RSIUnusual volumesTop GapsTop STIM

Top Movers
Top USATop CanadaTop U.K.Top GermanyTop EuropeTop Asia


 Tools
Market ScreenerDynamic chartFinancial calendarEconomic calendarSector researchCurrency converter

 Our Services
Premium AccessDiscover our Services

 



















 






4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography


Business Leaders




Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors HomeAll newsMost read newsBusiness Leaders Biography


 
















Vivian H. Liu

Age : 55Public asset : 95,449 USDLinked companies :  Cesca Therapeutics Inc -  Innovus Pharmaceuticals Inc 





Summary 



Ms. Vivian H. Liu is an Advisor at Brinson Patrick Securities Corp.She is on the Board of Directors at Innovus Pharmaceuticals, Inc. In 1995, she co-founded NexMed, Inc., which was renamed Apricus Biosciences, Inc. in 2010. Ms. Liu served as NexMed's President and Chief Executive Officer from 2007-2009 after having served in various executive capacities, including Executive Vice President and Chief Operating Officer, interim CEO, as well as Chief Financial Officer and Vice President of Corporate Affairs.Ms. Liu was appointed to the NEXM Board of Directors in 2007 and served as its Chairman of the Board from 2009 to 2010. Prior to co-founding NexMed, Ms. Liu was the Commercial Attach� with the Delegation of Quebec in Los Angeles, responsible for business development projects for the medical, pharmaceutical and biotechnology industries. Ms. Liu has an M.P.A. from the University of Southern California, and a B.A. from University of California, Berkeley.Ms. Liu is currently President & CEO of FasTrack Pharmaceuticals, Inc., a privately-held company focusing on the development of innovative pharmaceutical products.



Current positions of Vivian H. Liu 









 NameTitle
Since
 Cesca Therapeutics Inc(Pharmaceuticals)
Chief Operating Officer & Director
2016 Innovus Pharmaceuticals Inc(Pharmaceuticals)
Director
2011Brinson Patrick Securities Corp.
Advisor
-OxOnc Development LP
Partner
-



Holdings of Vivian H. Liu 










 NameEquities%Valuation

Innovus Pharmaceuticals, Inc.844,6830.56%95,449 USD
 Cesca Therapeutics Inc (KOOL) Pharmaceuticals 00.0000%0 USD



Vivian H. Liu: Personal Network 







 NameLinked companies

Joseph Thomis Cesca Therapeutics IncOxOnc Development LP 

Philip H. Coelho Cesca Therapeutics Inc 

Russell M. Medford Cesca Therapeutics Inc 

Mark Westgate Cesca Therapeutics Inc 

Mahendra S. Rao Cesca Therapeutics Inc 

Denis Michael Rhein Cesca Therapeutics Inc 

Xiao Chun Xu Cesca Therapeutics Inc 

Kimberly Kay Ellner Cesca Therapeutics Inc 

James Xu Cesca Therapeutics Inc 

Jeffery Cauble Cesca Therapeutics Inc 




Most Read News 




07/17 CHARLES SCHWAB : Low-fee BlackRock funds reel in cash but earnings disappoint



07/17DJCHARLES SCHARF : Bank of New York Mellon Names Former Visa Executive Scharf CEO and Chairman



07/17 PHILIP GREEN : You're hired - UK 'Apprentice' star Brady to chair Philip Green's company



07/17DJRUPERT MURDOCH : Tesla Names James Murdoch and Linda Johnson Rice to Board -- Update



07/17DJJAMES MURDOCH : Tesla Names James Murdoch and Linda Johnson to Board of Directors



07/18DJMARK LIGHT : Top Company News of the Day



07/18DJNELSON PELTZ : Peltz Goes on Offense In Break From Form -- WSJ



07/17 DAVID HENRY : Didn't pay your Macy's bill? Expect a text from Citigroup



07/17DJMARK LIGHT : Top Company News of the Day



07/15DJWARREN BUFFETT : Sprint Dials Up Buffett, Malone -- WSJ



More news

 


            © 2017 People and Ownership :    









Advertisement








Vivian H. Liu : Connections 



 Cesca Therapeutics Inc









Joseph ThomisPhilip H. CoelhoRussell M. MedfordMark WestgateMahendra S. RaoDenis Michael RheinXiao Chun XuKimberly Kay EllnerJames XuJeffery Cauble




 Catalyst Pharmaceuticals Inc









Philip H. Coelho




 Ampio Pharmaceuticals Inc









Philip H. Coelho




Synergenesis, Inc.
                                            








Philip H. Coelho





SynGen, Inc.
                                            








Philip H. Coelho





Emr Vermoegensverwaltung GmbH
                                            








Denis Michael Rhein





Viamune, Inc.
                                            








Russell M. Medford





OxOnc Development LP
                                            








Joseph Thomis





Biotechnology Innovation Organization
                                            








Russell M. Medford





Quotient Clinical Ltd.
                                            








Joseph Thomis





New York State Society of Certified Public Accountants
                                            








Mark Westgate





Southeast BIO
                                            








Russell M. Medford





Q Therapeutics, Inc.
                                            








Mahendra S. Rao





Georgia Global Health Alliance, Inc.
                                            








Russell M. Medford





Society of Cryobiology
                                            








Philip H. Coelho





US Food & Drug Administration
                                            








Mahendra S. Rao





Healthegames, Inc.
                                            








Russell M. Medford





Illumisound GmbH
                                            








Denis Michael Rhein





Salutria Pharmaceuticals, Inc.
                                            








Russell M. Medford





Boyalife Group Co. Ltd.
                                            








Xiao Chun Xu





 







Popular Business Leaders 


 

Bernard Arnault
Mary Barra
Lloyd Blankfein
Michael Bloomberg
Yannick Bollor�
Warren Buffett
Antony Burgmans
Jean-paul Clozel
Gary Cohn
Jamie Dimon
Ralph Dommermuth
Sebastian Ebel
John Edwards
David Einhorn
Jeff Fettig
Mark Fields
Carlos Ghosn
Terry Gou
David Henry
Carl Icahn
Li Ka-shing
Michel Landel
Daniel Loeb
Jack Ma
Marissa Mayer
Lakshmi Mittal
Oscar Munoz
Rupert Murdoch
Elon Musk
Peter Nicholas
John Paulson
Nelson Peltz
Georges Plassat
Hasso Plattner
Thomas Rabe
Giuseppe Recchi
Wolfgang Reitzle
Urs Rohner
Wilbur Ross
Charles Schwab
Igor Sechin
Pascal Soriot
George Soros
Rupert Stadler
Bernard Tapie
John Williamson
Thomas Wilson
Dieter Zetsche
Mark Zuckerberg



A-Z Business Leaders




 



























4-traders.com :MarketsNewsAnalysisStock PicksPortfoliosScreenersWatchlistsTop / FlopToolsOur ServicesAbout :Surperformance SASContact usAdvertiseLegal informationsAbout usStay Connected :FacebookTwitterPartners :B�rse: Aktien, Kurse und NachrichtenBest tweets 




   Copyright � 2017 Surperformance. All rights reserved.  












 














Slave










Insider Trading - Liu Vivian H - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Liu Vivian H





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-10-01Option Award
2016-11-2106:00 am
2016-10-012026-10-01
Innovus Pharmaceuticals Inc
INNV
Liu Vivian HDirector
11,538
$0.26
1,024,271(Direct)
View


2016-10-01Option Award
2016-11-2106:00 am
2016-11-162026-11-16
Innovus Pharmaceuticals Inc
INNV
Liu Vivian HDirector
416,667
$0.25
1,024,271(Direct)
View


2016-04-01Option Award
2016-07-159:50 pm
2016-04-012026-04-01
Innovus Pharmaceuticals Inc
INNV
Liu Vivian HDirector
44,709
$0.0671
596,066(Direct)
View


2016-04-01Option Award
2016-07-159:50 pm
2016-07-012026-07-01
Innovus Pharmaceuticals Inc
INNV
Liu Vivian HDirector
44,709
$0.2107
596,066(Direct)
View


2016-01-29Option Award
2016-02-026:06 pm
N/AN/A
Innovus Pharmaceuticals Inc
INNV
Liu Vivian HDirector
416,667
$0.04
537,532(Direct)
View


2016-01-04Option Award
2016-01-057:46 pm
N/AN/A
Innovus Pharmaceuticals Inc
INNV
Liu Vivian HDirector
42,857
$0.07
120,865(Direct)
View


2015-10-01Option Award
2015-10-029:50 pm
N/AN/A
Innovus Pharmaceuticals Inc
INNV
Liu Vivian HDirector
31,579
$0.095
78,008(Direct)
View


2015-07-02Option Award
2015-07-074:25 pm
N/AN/A
Innovus Pharmaceuticals Inc
INNV
Liu Vivian HDirector
25,000
$0.12
46,429(Direct)
View


2015-04-01Option Award
2015-04-033:01 pm
N/AN/A
Innovus Pharmaceuticals Inc
INNV
Liu Vivian HDirector
21,429
$0.14
21,429(Direct)
View


2015-03-31Option Award
2015-04-0106:20 am
N/AN/A
Innovus Pharmaceuticals Inc
INNV
Liu Vivian HDirector
500,000
$0
500,000(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 21 Jul 2017 11:20:16 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  











